Market Analyst
Descrizione dell'offerta
Krka is one of the leading international generic pharmaceutical companies, with over 70 years of history and more than 12,000 employees worldwide.
We manufacture and market prescription and non-prescription medicines, as well as animal health solutions, covering the entire production cycle: from the active ingredient to the finished product, through to validation via clinical trials.
Every year, we invest 10% of our turnover in research and development, and our goal is simple and ambitious: to make safe, effective and high-quality medicines accessible to all.
ROLE AND RESPONSIBILITIES
We are looking for a new member to join our Marketing team who, reporting to the General Manager, will be responsible for the following activities:
- Prepare analyses and reviews of marketing and other data
- Prepare presentations and reports of processed data to influence strategic choices, correct bad decisions and create personalized actions for users
- Create of BI reporting for the management and the field force
- Suggest new models and/or analysis in order to improve efficiency and overall results
- Forecasting, segmentation and clustering
- Monitor the effectiveness of marketing campaigns
- Respond to the needs of the different functions in terms of data and models
WHAT WE VALUE
- Solid Microsoft Office skills, especially with Excel
- Goal orientation and ability to work in a team
- Analytical skills and attention to details
- Proactivity and autonomy
- Fluent English
- Experience with market analysis, preferably in the pharmaceutical
- IQVIA platform knowledge is a plus
WE OFFER
- Permanent contract
- Dedicated development and training programs
- Competent, collaborative colleagues with a strong aptitude for teamwork
- Dynamic and international working environment
- Flexible working hours
Krka Farmaceutici will process personal data in accordance with current legislation on the protection of personal data, including EU Regulation 2016/679 and Legislative Decree 196/2003 as amended by Legislative Decree 101/2018.